The Effect of Bevacizumab on the Outcome of Trabeculectomy with 5-Fluorouracil

Journal of Ocular Pharmacology and Therapeutics

Volumn 29, Issue 7, 2013, Pages 646-651

  Suh, Wool ^a   Kee, Changwon ^b  

^a Hallym University College of Medicine   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; FLUOROURACIL;

ADULT; ARTICLE; BEST CORRECTED VISUAL ACUITY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FOLLOW UP; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; MALE; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; RANDOMIZED CONTROLLED TRIAL; TRABECULECTOMY; TREATMENT OUTCOME; VISUAL ACUITY;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIMETABOLITES, ANTINEOPLASTIC; CASE-CONTROL STUDIES; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; TRABECULECTOMY; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 84883275219     PISSN: 10807683     EISSN: 15577732     Source Type: Journal    
DOI: 10.1089/jop.2012.0250     Document Type: Article

References (34)

1. Falanga, V., Zitelli, J.A., and Eaglstein, W.H. Wound healing. J. Am. Acad. Dermatol. 19:559-563, 1988.
2. Steed, D.L. The role of growth factors in wound healing. Surg. Clin. North Am. 77:575-586, 1997.
3. The Fluorouracil Filtering Surgery Study Group. Five-year follow-up of the Fluorouracil Filtering Surgery Study. Am. J. Ophthalmol. 121:349-366, 1996.
4. Heuer, D.K., Parrish, R.K., 2nd, Gressel, M.G., Hodapp, E., Palmberg, P.F., and Anderson, D.R. 5-fluorouracil and glaucoma filtering surgery. II. A pilot study. Ophthalmology. 91:384-394, 1984.
5. Jampel, H.D. Effect of brief exposure to mitomycin C on viability and proliferation of cultured human Tenon's capsule fibroblasts. Ophthalmology. 99:1471-1476, 1992.
6. Khaw, P.T., Doyle, J.W., Sherwood, M.B., Grierson, I., Schultz, G., and McGorray, S. Prolonged localized tissue effects from 5-minute exposures to fluorouracil and mitomycin C. Arch. Ophthalmol. 111:263-267, 1993.
7. Khaw, P.T., Doyle, J.W., Sherwood, M.B., Smith, M.F., and McGorray, S. Effects of intraoperative 5-fluorouracil or mitomycin C on glaucoma filtration surgery in the rabbit. Ophthalmology. 100:367-372, 1993.
8. Liebmann, J.M., Ritch, R., Marmor, M., Nunez, J., and Wolner, B. Initial 5-fluorouracil trabeculectomy in uncomplicated glaucoma. Ophthalmology. 98:1036-1041, 1991.
9. Mora, J.S., Nguyen, N., Iwach, A.G., et al. Trabeculectomy with intraoperative sponge 5-fluorouracil. Ophthalmology. 103:963-970, 1996.
10. Smith, M.F., Doyle, J.W., Nguyen, Q.H., and Sherwood, M.B. Results of intraoperative 5-fluorouracil or lower dose mitomycin- C administration on initial trabeculectomy surgery. J. Glaucoma. 6:104-110, 1997.
11. Akarsu, C., Onol, M., and Hasanreisoglu, B. Postoperative 5- fluorouracil versus intraoperative mitomycin C in high-risk glaucoma filtering surgery: extended follow up. Clin. Exp. Ophthalmol. 31:199-205, 2003.
12. Beckers, H.J., Kinders, K.C., and Webers, C.A. Five-year results of trabeculectomy with mitomycin C. Graefes Arch. Clin. Exp. Ophthalmol. 241:106-110, 2003.
13. Goldenfeld, M., Krupin, T., Ruderman, J.M., et al. 5- Fluorouracil in initial trabeculectomy. A prospective, randomized, multicenter study. Ophthalmology. 101:1024-1029, 1994.
14. Scott, I.U., Greenfield, D.S., Schiffman, J., et al. Outcomes of primary trabeculectomy with the use of adjunctive mitomycin. Arch. Ophthalmol. 116:286-291, 1998.
15. Asahara, T., Bauters, C., Zheng, L.P., et al. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation. 92:II365- II371, 1995.
16. Dvorak, H.F., Brown, L.F., Detmar, M., and Dvorak, A.M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol. 146:1029-1039, 1995.
17. Seghezzi, G., Patel, S., Ren, C.J., et al. Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis. J. Cell Biol. 141:1659-1673, 1998.
18. Grewal, D.S., Jain, R., Kumar, H., and Grewal, S.P. Evaluation of subconjunctival bevacizumab as an adjunct to trabeculectomy a pilot study. Ophthalmology. 115:2141-2145 e2142, 2008.
19. Jonas, J.B., Spandau, U.H., and Schlichtenbrede, F. Intravitreal bevacizumab for filtering surgery. Ophthalmic. Res. 39:121-122, 2007.
20. Kahook, M.Y., Schuman, J.S., and Noecker, R.J. Needle bleb revision of encapsulated filtering bleb with bevacizumab. Ophthalmic. Surg. Lasers Imaging. 37:148-150, 2006.
21. Addicks, E.M., Quigley, H.A., Green, W.R., and Robin, A.L. Histologic characteristics of filtering blebs in glaucomatous eyes. Arch. Ophthalmol. 101:795-798, 1983.
22. Hitchings, R.A., and Grierson, I. Clinico pathological correlation in eyes with failed fistulizing surgery. Trans. Ophthalmol. Soc. U. K. 103 (Pt 1):84-88, 1983.
23. Fontana, H., Nouri-Mahdavi, K., Lumba, J., Ralli, M., and Caprioli, J. Trabeculectomy with mitomycin C: outcomes and risk factors for failure in phakic open-angle glaucoma. Ophthalmology. 113:930-936, 2006.
24. Singh, R.P., Goldberg, I., and Mohsin, M. The efficacy and safety of intraoperative and/or postoperative 5-fluorouracil in trabeculectomy and phacotrabeculectomy. Clin. Exp. Ophthalmol. 29:296-302, 2001.
25. Veronese, M.L., and O'Dwyer, P.J. Monoclonal antibodies in the treatment of colorectal cancer. Eur. J. Cancer. 40:1292-1301, 2004.
26. Li, Z., Van Bergen, T., Van de Veire, S., et al. Inhibition of vascular endothelial growth factor reduces scar formation after glaucoma filtration surgery. Invest. Ophthalmol. Vis. Sci. 50:5217-5225, 2009.
27. Chalam, K.V., Gupta, S.K., Grover, S., Brar, V.S., and Agarwal, S. Intracameral Avastin dramatically resolves iris neovascularization and reverses neovascular glaucoma. Eur. J. Ophthalmol. 18:255-262, 2008.
28. Adelman, R.A., Zheng, Q., and Mayer, H.R. Persistent ocular hypertension following intravitreal bevacizumab and ranibizumab injections. J. Ocul. Pharmacol. Ther. 26:105-110, 2010.
29. Horsley, M.B., and Kahook, M.Y. Anti-VEGF therapy for glaucoma. Curr. Opin. Ophthalmol. 21:112-117, 2010.
30. Memarzadeh, F., Varma, R., Lin, L.T., et al. Postoperative use of bevacizumab as an antifibrotic agent in glaucoma filtration surgery in the rabbit. Invest. Ophthalmol. Vis. Sci. 50:3233-3237, 2009.
31. Gordon, C.R., Rojavin, Y., Patel, M., et al. A review on bevacizumab and surgical wound healing: an important warning to all surgeons. Ann. Plast. Surg. 62:707-709, 2009.
32. Scappaticci, F.A., Fehrenbacher, L., Cartwright, T., et al. Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab. J. Surg. Oncol. 91:173-180, 2005.
33. Coote, M.A., Ruddle, J.B., Qin, Q., and Crowston, J.G. Vascular changes after intra-bleb injection of bevacizumab. J. Glaucoma. 17:517-518, 2008.
34. Georgalas, I., Papaconstantinou, D., Tservakis, I., Koutsandrea, C., and Ladas, I. Severe hypotony and filtering bleb leak after intravitreal injection of ranibizumab. Ther. Clin. Risk. Manag. 5:17-19, 2009.